Want to see IN:NATHBIOGEN full AI Analyst Report?
Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Revenue
Nath Bio-Genes (India) Ltd. Revenue
Nath Bio-Genes (India) Ltd. had a revenue of 3.28B in the quarter ending Jun 30, 2026, with 536.53%. This bring the company's revenue in the last twelve months to 4.90B, Increased 10.04%. In the fiscal year ending Mar 31, 2026, Nath Bio-Genes (India) Ltd. had annual revenue of 4.45B with 21.98% growth.
- Revenue (ttm)
- 4.90B
- Revenue Growth
- 21.02%
- P/S Ratio
- 0.56
- Revenue/Employee
- INR 9,847,378
- Employees
- 452
- Market Cap
- INR 2.50B
Revenue Chart
Nath Bio-Genes (India) Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.45B | 801.93M | 21.98% |
| Mar 31, 2025 | 3.65B | 1.17B | 47.42% |
| Mar 31, 2024 | 2.48B | -537.65M | -17.85% |
| Mar 31, 2023 | 3.01B | 229.31M | 8.24% |
| Mar 31, 2022 | 2.78B | -289.84M | -9.43% |
| Mar 31, 2021 | 3.07B | 274.57M | 9.81% |
| Mar 31, 2020 | 2.80B | 493.32M | 21.40% |
| Mar 31, 2019 | 2.31B | 389.23M | 20.31% |
| Mar 31, 2018 | 1.92B | 219.07M | 12.91% |
| Mar 31, 2017 | 1.70B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:NATHBIOGEN | 4.90B |
| IN:DHANUKA | 19.53B |
| IN:INSECTICID | 20.60B |
| IN:IPL | 10.57B |
| IN:RALLIS | 29.59B |
| IN:SHARDACROP | 53.57B |